Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Воспалительные заболевания органов малого таза: современная тактика терапии
Воспалительные заболевания органов малого таза: современная тактика терапии
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Воспалительные заболевания органов малого таза (ВЗОМТ) включают широкий спектр воспалительных процессов, часто ассоциированных с инфекциями, передающимися половым путем (ИППП). В большом числе случаев ВЗОМТ протекают атипично или имеют стертые клинические проявления. Эмпирическая терапия ВЗОМТ обязательна у сексуально активных молодых женщин и в группах риска по ИППП при наличии симптомов воспаления. Парентеральные и пероральные режимы терапии должны перекрывать весь спектр возможных возбудителей, вызывающих ИППП, а также анаэробы и миклофлору, ассоциированную с бактериальным вагинозом.
Ключевые слова: ВЗОМТ, воспаление, ИППП.
Key words: PID, inflammation, STD.
Ключевые слова: ВЗОМТ, воспаление, ИППП.
________________________________________________
Key words: PID, inflammation, STD.
Полный текст
Список литературы
1. Boeke AJ. The risk of pelvic inflammatory disease with urogenital infection with Chlamydia trachomatis. Ned Tijdschr Geneeskd 2005; 16 (149): 878–84.
2. CDC. Sexually Transmitted Disease Treatment Guidelines. Pelvic Inflammatory Disease. MMWR 2010; 59: RR-12.
3. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
4. RCOG Green Top Guidelines-Management of Pelvic Inflammatory Disease (2003, 2009) (www.rcog.org.uk)
5. Clarke LM, Duerr А, Yeung КН. Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease. J Infect Dis 1997; 1 (176): 286–8.
6. Cohen CR. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
7. Гинекология: национальное руководство. Под ред. В.И.Кулакова, И.Б.Манухина, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2011.
8. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 753037.
9. Blake DR. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol 2003; 1 (16): 25–30.
10. Korn AP. Risk factors for plasma cell endometritis among women with cervical Chlamydia trachomatis, cervical Neisseria gonorrhoeae, or bacterial vaginosis. Am J Obstet Gynecol 1998; 5 (178): 987–90.
11. Lin HW, Tu YY, Lin SY. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol 2011; 12 (9): 900–4.
12. Hillis SD, Joesoef R, Marchbanks PA et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 163: 1503–9.
13. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. М., 2002.
14. Ness RB, Soper DE, Holley RL. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trail. American J Obstet Gynecol 2002; 186: 929–37.
15. Ross JD. Outpatient antibiotics for pelvic inflammatory disease. BMJ 2001; 322: 251–2.
16. Low N, Welch J, Radcliff K. Developing national outcome standards for the management of gonorrhea and genital Chlamydia in genitourinary medicine clinics. Sex Trans Infect 2004; 80: 223–9.
17. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299–305.
18. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61–70.
2. CDC. Sexually Transmitted Disease Treatment Guidelines. Pelvic Inflammatory Disease. MMWR 2010; 59: RR-12.
3. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
4. RCOG Green Top Guidelines-Management of Pelvic Inflammatory Disease (2003, 2009) (www.rcog.org.uk)
5. Clarke LM, Duerr А, Yeung КН. Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease. J Infect Dis 1997; 1 (176): 286–8.
6. Cohen CR. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
7. Гинекология: национальное руководство. Под ред. В.И.Кулакова, И.Б.Манухина, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2011.
8. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 753037.
9. Blake DR. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol 2003; 1 (16): 25–30.
10. Korn AP. Risk factors for plasma cell endometritis among women with cervical Chlamydia trachomatis, cervical Neisseria gonorrhoeae, or bacterial vaginosis. Am J Obstet Gynecol 1998; 5 (178): 987–90.
11. Lin HW, Tu YY, Lin SY. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol 2011; 12 (9): 900–4.
12. Hillis SD, Joesoef R, Marchbanks PA et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 163: 1503–9.
13. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. М., 2002.
14. Ness RB, Soper DE, Holley RL. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trail. American J Obstet Gynecol 2002; 186: 929–37.
15. Ross JD. Outpatient antibiotics for pelvic inflammatory disease. BMJ 2001; 322: 251–2.
16. Low N, Welch J, Radcliff K. Developing national outcome standards for the management of gonorrhea and genital Chlamydia in genitourinary medicine clinics. Sex Trans Infect 2004; 80: 223–9.
17. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299–305.
18. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61–70.
2. CDC. Sexually Transmitted Disease Treatment Guidelines. Pelvic Inflammatory Disease. MMWR 2010; 59: RR-12.
3. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
4. RCOG Green Top Guidelines-Management of Pelvic Inflammatory Disease (2003, 2009) (www.rcog.org.uk)
5. Clarke LM, Duerr А, Yeung КН. Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease. J Infect Dis 1997; 1 (176): 286–8.
6. Cohen CR. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
7. Гинекология: национальное руководство. Под ред. В.И.Кулакова, И.Б.Манухина, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2011.
8. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 753037.
9. Blake DR. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol 2003; 1 (16): 25–30.
10. Korn AP. Risk factors for plasma cell endometritis among women with cervical Chlamydia trachomatis, cervical Neisseria gonorrhoeae, or bacterial vaginosis. Am J Obstet Gynecol 1998; 5 (178): 987–90.
11. Lin HW, Tu YY, Lin SY. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol 2011; 12 (9): 900–4.
12. Hillis SD, Joesoef R, Marchbanks PA et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 163: 1503–9.
13. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. М., 2002.
14. Ness RB, Soper DE, Holley RL. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trail. American J Obstet Gynecol 2002; 186: 929–37.
15. Ross JD. Outpatient antibiotics for pelvic inflammatory disease. BMJ 2001; 322: 251–2.
16. Low N, Welch J, Radcliff K. Developing national outcome standards for the management of gonorrhea and genital Chlamydia in genitourinary medicine clinics. Sex Trans Infect 2004; 80: 223–9.
17. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299–305.
18. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61–70.
________________________________________________
2. CDC. Sexually Transmitted Disease Treatment Guidelines. Pelvic Inflammatory Disease. MMWR 2010; 59: RR-12.
3. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
4. RCOG Green Top Guidelines-Management of Pelvic Inflammatory Disease (2003, 2009) (www.rcog.org.uk)
5. Clarke LM, Duerr А, Yeung КН. Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease. J Infect Dis 1997; 1 (176): 286–8.
6. Cohen CR. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765–6.
7. Гинекология: национальное руководство. Под ред. В.И.Кулакова, И.Б.Манухина, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2011.
8. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 753037.
9. Blake DR. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol 2003; 1 (16): 25–30.
10. Korn AP. Risk factors for plasma cell endometritis among women with cervical Chlamydia trachomatis, cervical Neisseria gonorrhoeae, or bacterial vaginosis. Am J Obstet Gynecol 1998; 5 (178): 987–90.
11. Lin HW, Tu YY, Lin SY. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol 2011; 12 (9): 900–4.
12. Hillis SD, Joesoef R, Marchbanks PA et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 163: 1503–9.
13. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. М., 2002.
14. Ness RB, Soper DE, Holley RL. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trail. American J Obstet Gynecol 2002; 186: 929–37.
15. Ross JD. Outpatient antibiotics for pelvic inflammatory disease. BMJ 2001; 322: 251–2.
16. Low N, Welch J, Radcliff K. Developing national outcome standards for the management of gonorrhea and genital Chlamydia in genitourinary medicine clinics. Sex Trans Infect 2004; 80: 223–9.
17. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299–305.
18. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61–70.
Авторы
А.В.Шуршалина
Американский медицинский центр, Москва
Американский медицинский центр, Москва
________________________________________________
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.